Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in the United Kingdom. It focuses on Bipolarity.
In United KingdomThis study was terminated in the United Kingdom. It is testing brief cognitive behavioural therapy for depression.
In United Kingdom
This study is ongoing in the United Kingdom. It is testing randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo and standard psychological care for depression.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on Schizophrenia.
In United Kingdom
This study is ongoing in the United Kingdom. It is testing lithium and quetiapine augmentation for treatment-resistant depression.
In United KingdomThis study is ongoing in the United Kingdom. It is testing IP2018 for Depression.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on manic episodes in bipolarity.
In United KingdomThis study is ongoing in the United Kingdom. It is testing randomised, placebo controlled trial of psilocybin for treatment-resistant depression.
In United KingdomThis study is ongoing in the United Kingdom and . It focuses on depression.
In United KingdomThis study is ongoing in the United Kingdom and . It is testing SAGE-217 for depression.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on Anxiety.
In United KingdomThis study is completed. It focuses on PTSD and currently lists study information in the United Kingdom.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.